主题一 ： Nanomedicine in Metabolic Disorders: Exploring innovative nanotechnology-based approaches for the diagnosis and treatment of metabolic diseases （ 纳米医学在代谢性疾病中的应 用：探索基于纳米技术的创新诊断与治疗方法） 编辑丨王多鱼 排版丨水成文 细胞 作为生命的基本单元，其复杂而精妙的机制一直是生物医学研究的核心。 组织屏障功能与细胞连、受 体信号网络、细胞酶抑制研究、淀粉样蛋白研究、未来医疗革命 等等方面都备受 细胞生物学 科研人员的 重点关注！本文整合了部分 全球热门征稿 和 高影响力期刊 ，欢迎下滑查看！ 全球热门征稿 该主题将突出利用纳米材料和设备来改善药物递送，提高诊断精度，并提供有针对性的治疗干预的前沿研 究。邀请的研究成果包括靶向药物递送的新型纳米载体，纳米级诊断平台，智能生物材料，以及结合治疗 和诊断能力的综合治疗系统。 截稿日期： 2026 年 3 月 31 日 所属期刊： Artificial Cells, Nanomedicine, ...

Core Viewpoint - Hu Ye, a prominent biomedical scientist, has returned to China after 22 years in the U.S., criticizing the Trump administration's funding cuts to the NIH, which totaled $8.3 million, impacting critical research areas [1][3]. Group 1: Background and Career - Hu Ye served as a professor at Tulane University and has a strong academic background, having graduated from Lanzhou University and Tsinghua University, and obtained advanced degrees from the University of Texas [6][7]. - He has held various prestigious positions, including founding director of the Intelligent Molecular Diagnostics Center and has been involved in significant research projects funded by institutions like the NIH and the Gates Foundation [7][8]. Group 2: Research Impact and Funding Cuts - Hu Ye publicly warned that the proposed federal budget could reduce NIH's indirect cost reimbursement rate from 53% to 15%, which would severely affect scientific research [3]. - Specific NIH funding cuts include $3.7 million for early detection of tuberculosis and HIV in children, $3.1 million for blood-based cancer detection technology, and $1.5 million for advanced equipment procurement [3]. Group 3: Contributions to Biomedical Research - Hu Ye has focused on rapid virus detection and has published extensively in top journals, holding over 30 patents in nanomedicine [3][6]. - His laboratory developed a rapid COVID-19 testing kit that uses saliva and provides results in 15 minutes, showcasing his innovative contributions to public health [6][7]. Group 4: Future Directions at Tsinghua University - Upon returning to China, Hu Ye has taken on the role of Dean at Tsinghua University's School of Biomedical Engineering, aiming to advance research in infectious diseases, neurological disorders, and cancer diagnostics [7][8]. - His leadership is expected to enhance Tsinghua's position in the international biomedical field, as noted by the university's vice president [8].

Group 1 - The 2025 China Biomedical Engineering Conference and Innovation Medical Summit opened in Suzhou, highlighting the city's role as a hub for biomedical innovation and high-end medical device R&D [1][2] - The conference aims to encourage young scholars to showcase their talents and achievements, fostering collaboration between the China Biomedical Engineering Society and Suzhou in talent cultivation, technology R&D, and achievement transformation [1] - The conference theme is "Integration of Medicine and Engineering, Innovation Leading the Future," focusing on key areas such as artificial intelligence, smart healthcare, nanomedicine, organoids and organ-on-chip technology, regenerative medicine, medical imaging, medical robotics, biomanufacturing, and life support systems [2] Group 2 - The conference features keynote speeches from academicians, annual thematic forums, 21 sub-venues, and 15 sub-forums, along with competitions for young papers, innovative project roadshows, and entrepreneurship contests for comprehensive academic exchange and achievement display [2] - The opening ceremony included the awarding of the Huang Jiasu Biomedical Engineering Award for 2024-2025 and the presentation of fellow certificates from the China Biomedical Engineering Society [2]